Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds
Authors:
- Eric RhodenEREric Rhoden
- Hong-Mei LiuHLHong-Mei Liu
- Shur-Wern Wang-ChernSWShur-Wern Wang-Chern
- M. Steven ObersteMOM. Steven Oberste
- 1 May 2013
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 98 (2) , 186-191
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine‐Derived Polioviruses (cVDPVs)Risk Analysis, 2013
- Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073Antimicrobial Agents and Chemotherapy, 2012
- A case for developing antiviral drugs against polioAntiviral Research, 2008
- Potential Use of Antiviral Agents in Polio EradicationEmerging Infectious Diseases, 2008
- Selective inhibitors of picornavirus replicationMedicinal Research Reviews, 2008
- Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing PeptidomimeticsJournal of Medicinal Chemistry, 2003
- In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses1Antiviral Research, 2000
- SCH 48973: a potent, broad-spectrum, antienterovirus compoundAntimicrobial Agents and Chemotherapy, 1997
- TREATMENT OF THE PICORNA VIRUS COMMON COLD BY INHIBITORS OF VIRAL UNCOATING AND ATTACHMENTAnnual Review of Microbiology, 1992
- Three-Dimensional Structure of Poliovirus at 2.9 Å ResolutionScience, 1985